Skip to main content
ANTEOTECH LTD logo

ANTEOTECH LTD — Investor Relations & Filings

Ticker · ADO ISIN · AU000000ADO8 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,280 across all filing types
Latest filing 2017-09-04 Regulatory Filings
Country AU Australia
Listing ASX ADO

About ANTEOTECH LTD

https://anteotech.com

AnteoTech Ltd is a surface chemistry company specializing in the development of proprietary nanoglue technology. The company focuses on two primary sectors: life sciences and energy. In the life sciences division, AnteoTech utilizes its AnteoBind molecular linker technology to enhance the performance of point-of-care diagnostic tests, bioprocessing, and assay development by improving the binding of biomolecules to synthetic surfaces. In the energy sector, the company develops advanced materials for lithium-ion batteries, specifically focusing on silicon anodes. Its AnteoX additive is designed to improve the electrochemical performance and structural stability of high-silicon content anodes, addressing capacity loss and cycle life challenges. The company's core value proposition lies in its ability to manipulate surface interfaces at the molecular level to optimize performance in complex chemical and biological environments.

Recent filings

Filing Released Lang Actions
Section 708A(5)(e) Cleansing Notice 1 page 74.7KB
Regulatory Filings Classification · 95% confidence The document is a notice under section 708A of the Corporations Act 2001 (Cth) regarding the issue of new shares by Anteo Diagnostics Ltd. It explains the legal basis for the exemption from disclosure requirements for the sale of these shares. The content is regulatory in nature, related to compliance with securities law, and does not contain financial statements, management discussion, or detailed financial data. The document length is short (1736 characters) and it is a formal announcement to the Australian Securities Exchange. This fits the category of a Regulatory Filing (RNS), as it is a compliance announcement that does not fit into other specific categories like capital changes or share issues because it is primarily a legal notice about disclosure exemption rather than a direct capital change announcement or share issue notice.
2017-09-04 English
Appendix 3B 11 pages 154.0KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, specifically ordinary shares. It includes detailed information about the number of securities issued, their terms, issue price, purpose of the issue, and compliance with ASX rules. The document also contains sections on quotation of securities and calculation of placement capacity under ASX rules. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a formal announcement of a capital raising event and application for quotation of additional securities on the ASX. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2017-08-31 English
Preliminary Final Report - Schedule 4E 9 pages 181.3KB
Regulatory Filings Classification · 95% confidence The document is titled '30 June 2017 Preliminary Financial Statements' and is dated 1 September 2017. It includes detailed financial data such as consolidated statements of profit or loss, financial position, cash flows, and notes to the income statement. It also discusses significant events like the sale of a subsidiary and classifies assets and liabilities accordingly. The document is unaudited preliminary financial statements and is referred to as an 'Appendix 4E Preliminary Final Report,' which is a regulatory filing used in Australia to announce preliminary final results before the audited annual report is published. The document contains substantive financial data and analysis for the year ended 30 June 2017, but it is not the full audited annual report (10-K equivalent). It is a comprehensive financial report for a full fiscal year but preliminary and unaudited. Given the detailed financial statements and analysis, this fits best under the category of Interim / Quarterly Report (IR) as it is a preliminary final report for the full year but not the final audited annual report. However, since it covers a full fiscal year and is preliminary, it is not a typical quarterly or interim report. The document is not an announcement of a report but the report itself. The best fitting category is Regulatory Filings (RNS) because Appendix 4E is a regulatory announcement of preliminary final results, not the full Annual Report (10-K). Therefore, the classification is RNS with high confidence.
2017-08-31 English
Management changes resulting from sale of DIAsource 1
Board/Management Information Classification · 100% confidence The document announces management changes resulting from the sale of a subsidiary (DIAsource). It details the resignation of the CEO and appointment of an interim executive chairman, including compensation details and strategic intentions. There is no financial data, no mention of a report or filing, and the content focuses solely on board and senior management changes. This fits the definition of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing, but a direct announcement of management changes.
2017-08-31 English
Anteo enters into unconditional agreement to sell DIAsource 3 pages 139.3KB
Capital/Financing Update Classification · 95% confidence The document is an announcement by Anteo Diagnostics Limited regarding the unconditional agreement to sell its subsidiary DIAsource. It details the transaction terms, expected financial impacts, use of proceeds, and strategic implications. The content focuses on a capital transaction involving the sale of a business unit, repayment of debts, and share issuance related to the transaction. There are no detailed financial statements or comprehensive financial performance data typical of annual or interim reports. The document is not a full earnings release but rather a specific update on a financing and capital restructuring event. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (7,221 characters) and detailed transaction information support this classification with high confidence.
2017-08-31 English
Company Secretary Appointment/Resignation 1 page 75
Board/Management Information Classification · 95% confidence The document is a short announcement dated 28 August 2017 about the appointment of a new Company Secretary for Anteo Diagnostics Limited. It provides background information about the appointee and the company but does not contain financial data, regulatory filings, or detailed reports. The content clearly relates to a change in senior management position. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (2186 characters), consistent with a brief announcement rather than a full report.
2017-08-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.